Fiducial markers and their impact on ablation outcome for patients treated with MR-guided transurethral ablation (TULSA): a retrospective technical analysis-Reference-Cited by-同舟云学术

Fiducial markers and their impact on ablation outcome for patients treated with MR-guided transurethral ablation (TULSA): a retrospective technical analysis

Published:2021-01-01 Issue:1 Volume:38 Page:1677-1684
ISSN:0265-6736
Container-title:International Journal of Hyperthermia
language:en
Short-container-title:International Journal of Hyperthermia

Author:

Wright Cameron¹²^ORCID,Mäkelä Pietari²,Anttinen Mikael¹,Sainio Teija³^ORCID,Boström Peter J.¹,Blanco Sequeiros Roberto²^ORCID

Affiliation:

1. Department of Urology, University of Turku and Turku University Hospital, Turku, Finland

2. Department of Diagnostic Radiology, University of Turku and Turku University Hospital, Turku, Finland

3. Department of Medical Physics and Nuclear Medicine, University of Turku and Turku University Hospital, Turku, Finland

Publisher

Informa UK Limited

Subject

Cancer Research,Physiology (medical),Physiology

Link

https://www.tandfonline.com/doi/pdf/10.1080/02656736.2021.2008519

Reference25 articles.

1. Surgery Versus Radiotherapy for Clinically-localized Prostate Cancer: A Systematic Review and Meta-analysis

2. Fiducial marker guided prostate radiotherapy: a review

3. EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part II: Treatment of Relapsing, Metastatic, and Castration-Resistant Prostate Cancer

4. Nonsurgical Salvage Local Therapies for Radiorecurrent Prostate Cancer: A Systematic Review and Meta-analysis

5. Magnetic Resonance Imaging-Guided Transurethral Ultrasound Ablation of Prostate Cancer

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety and efficacy of MRI-guided transurethral ultrasound ablation for radiorecurrent prostate cancer in the presence of gold fiducial markers;Acta Radiologica;2022-06-24